Bipolar Disorders
Jonathan Meyer, MD
Voluntary Clinical Professor of Psychiatry
University of California, San Diego
University of California, San Diego
Clinicians who treat patients with a history of mania historically turned to lithium as the go-to mood stabilizer. More recently, concerns about renal and other adverse effects have led some to approach this treatment option with caution. This presentation aims to provide clinicians with the most up-to-date information on lithium's role in treating bipolar patients, including dosing, kinetics, and target serum levels. Additionally, the presentation will cover the latest studies on lithium use during breastfeeding and the most recent risk estimates for first-trimester exposure during pregnancy. By the end of the session, clinicians will be equipped with the knowledge needed to use lithium confidently and effectively in their practice.